|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2250 CAD | 0.00% |
|
-13.46% | +36.36% |
| 11-20 | Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| 11-20 | Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025 |
Projected Income Statement: Vext Science, Inc.
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 25.19 | 37.24 | 35.41 | 34.81 | 36 | 51.5 | 59.57 | 73.48 |
| Change | - | 47.83% | -4.92% | -1.69% | 3.4% | 43.07% | 15.67% | 23.34% |
| EBITDA 1 | 6.813 | 13.39 | 15.12 | 5.528 | 9.153 | 12.3 | 21 | - |
| Change | - | 96.61% | 12.87% | -63.44% | 65.58% | 34.39% | 70.73% | - |
| EBIT | 4.686 | - | - | -7.843 | -11.18 | - | - | - |
| Change | - | - | - | - | -42.55% | - | - | - |
| Interest Paid 1 | -0.6194 | - | - | -3.812 | -3.331 | -3.053 | -1.935 | -0.3622 |
| Earnings before Tax (EBT) 1 | 2.639 | - | - | - | - | -8.606 | -4.644 | 2.595 |
| Change | - | - | - | - | - | - | 46.04% | 155.88% |
| Net income 1 | 2.125 | - | - | - | - | -11.63 | -6.211 | 0.7469 |
| Change | - | - | - | - | - | - | 46.61% | 112.03% |
| Announcement Date | 15/04/21 | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: Vext Science, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 7.64 | 32.2 | 29.9 | 34.9 | 30.7 | 26 | - |
| Change | - | - | 321.47% | -7.14% | 16.72% | -12.02% | -15.31% | - |
| Announcement Date | 15/04/21 | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: Vext Science, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| CAPEX 1 | 4.063 | 18.78 | 8.86 | 2.737 | 1.465 | 3.3 | 1.2 |
| Change | - | 362.26% | -52.83% | -69.11% | -46.46% | 125.21% | -63.64% |
| Free Cash Flow (FCF) 1 | -9.803 | -7.102 | -2.938 | 1.688 | 1.823 | 6.7 | 5.8 |
| Change | - | 27.55% | 58.64% | 157.45% | 8.04% | 267.47% | -13.43% |
| Announcement Date | 15/04/21 | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | - | - |
1CAD in Million
Estimates
Forecast Financial Ratios: Vext Science, Inc.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
| EBITDA Margin (%) | - | 27.04% | 35.96% | 42.69% | 15.88% | 25.43% | 23.88% | 35.25% | - |
| EBIT Margin (%) | - | 18.6% | - | - | -22.53% | -31.06% | - | - | - |
| EBT Margin (%) | - | 10.48% | - | - | - | - | -16.71% | -7.8% | 3.53% |
| Net margin (%) | - | 8.43% | - | - | - | - | -22.59% | -10.43% | 1.02% |
| FCF margin (%) | - | -38.91% | -19.07% | -8.3% | 4.85% | 5.06% | 13.01% | 9.74% | - |
| FCF / Net Income (%) | - | -461.28% | - | - | - | - | -57.6% | -93.39% | - |
Profitability | |||||||||
| ROA | 7.2% | 4.29% | 7.17% | 5.67% | -3.62% | -5.04% | - | - | - |
| ROE | 13.09% | 6.86% | 10.42% | 16.63% | 5.27% | -26.28% | - | - | - |
Financial Health | |||||||||
| Leverage (Debt/EBITDA) | - | - | 0.57x | 2.13x | 5.4x | 3.81x | 2.5x | 1.24x | - |
| Debt / Free cash flow | - | - | -1.08x | -10.97x | 17.7x | 19.14x | 4.58x | 4.48x | - |
Capital Intensity | |||||||||
| CAPEX / Current Assets (%) | - | 16.13% | 50.43% | 25.02% | 7.86% | 4.07% | 6.41% | 2.01% | - |
| CAPEX / EBITDA (%) | - | 59.65% | 140.24% | 58.61% | 49.52% | 16.01% | 26.83% | 5.71% | - |
| CAPEX / FCF (%) | - | -41.45% | -264.47% | -301.62% | 162.18% | 80.37% | 49.25% | 20.69% | - |
Items per share | |||||||||
| Cash flow per share 1 | - | - | 0.1008 | 0.0583 | 0.0367 | 0.0197 | 0.06 | 0.06 | - |
| Change | - | - | - | -42.2% | -37.04% | -46.35% | 204.72% | 0% | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| EPS 1 | - | 0.0251 | - | - | 0.041 | -0.115 | -0.069 | -0.042 | - |
| Change | - | - | - | - | - | -380.53% | 39.99% | 39.13% | - |
| Nbr of stocks (in thousands) | - | 115,153 | 136,713 | 148,963 | 217,484 | 247,443 | 247,684 | 247,684 | 247,684 |
| Announcement Date | - | 15/04/21 | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | - | - | - |
1CAD
Estimates
| 2025 * | 2026 * | |
|---|---|---|
| P/E ratio | -3.26x | -5.36x |
| PBR | - | - |
| EV / Sales | 1.38x | 1.11x |
| Yield | - | - |
More valuation ratios
* Estimated data
EPS & Dividend
Y-o-Y evolution of P/E
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2250CAD
Average target price
0.6750CAD
Spread / Average Target
+200.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VEXT Stock
- Financials Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















